Search results
Added:
3 years ago
The overall increase in patient irradiation caused by the growing use of spiral- and multidetector-row computed tomography (MDCT) is of particular relevance for thoracic imaging. The number of clinical indications for thoracic CT has steadily increased, and CT has become a first-line imaging tool for diseases previously imaged with chest radiography, ventilation/perfusion scintigraphy and…
View more
Added:
5 years ago
Prof Marianne Brodmann (Medical University of Graz, AT) discusses safety of pacilitaxel coated balloons.
Filmed on site by Radcliffe Cardiology.
Questions:
1.There have been safety concerns with paclitaxel DCB's. What is your take on this? (00:09)
2.Are you still implanting drug coated balloons? (02:16)
View more
Added:
4 years ago
GEMINI-ACS - Comparison of the Safety of Rivaroxaban Versus Aspirin in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome.
Interview with Professor E. Magnus Ohman from Duke University Medical Center, Durham, North Carolina, USA at ACC 2017.
View more
Added:
3 years ago
An unintended consequence of the market success of drug-eluting stents has been a growing concern about their safety and safety-related costs. These devices have been so quickly and widely adopted that their market penetration already equals that of some of the most popular pharmaceutical drugs. Consequently, the absolute significance of even a low incidence of side effects becomes magnified by…
View more
Added:
6 years ago
This interview with Steven E. Nissen from Cleveland Clinic, Cleveland, US discusses Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen (PRECISION).
Filmed by Radcliffe Cardiology on-site at ESC 2017.
View more
Added:
1 year ago
ACC.23/WCC—We are joined by Dr Christie Ballantyne (Baylor College of Medicine, US) to discuss the results of a phase 2b clinical trial on the efficacy and safety of MK-0616, an oral macrocyclic PCSK9 inhibitor.In this trial sponsored by Merck Sharp & Dohme LLC, MK-0616 was compared to a placebo in over 380 participants with hypercholesterolemia, whose low-density lipoprotein cholesterol (LDL-C)…
View more
Added:
3 years ago
Atrial fibrillation (AF) is defined as a supraventricular tachycardia with rapid uncoordinated atrial activation, beat-to-beat irregularity and frequently rapid ventricular rate.2 It is the most frequently observed sustained arrhythmia in clinical practice.3 An estimated 12 million individuals in the EU and 2.3–10 million in the US have AF, and these numbers are expected to increase as the age of…
View more
Added:
3 years ago
Drug-eluting stents (DESs) have significantly improved the effectiveness of percutaneous revascularisation procedures. Since the initial experiences with the first devices, now called ‘first-generation’, DESs have proved very effective in reducing restenosis.1–3 The ‘second-generation’ DESs were conceived to have at least the same standards of efficacy than their predecessors, but with improved…
View more
Added:
12 months ago
Added:
3 years ago
An unintended consequence of the market success of drug-eluting stents has been a growing concern about their safety and safety-related costs. These devices have been so quickly and widely adopted that their market penetration already equals that of some of the most popular pharmaceutical drugs. Consequently, the absolute significance of even a low incidence of side effects becomes magnified by…
View more
